Kadhim, A. A., Jamal, M. Y., & Karim, A. K. (2025). Natalizumab Immunogenicity in Multiple Sclerosis: Evaluating Antibody Development and Clinical Outcomes in an Iraqi Cohort. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ), 9(2), 83–89. https://doi.org/10.54133/ajms.v9i2.2352